Medical Disclosure

Not medical advice

Information surfaced by Veyda — including Sage's reasoning, Roundtable summaries, lab interpretation, and wearable insights — is for informational and wellness purposes only. It is not a substitute for the advice, diagnosis, or treatment of a licensed healthcare provider.

Always seek the advice of your physician or other qualified health professional with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you read or heard inside Veyda.

Where Veyda care services apply

Some Veyda memberships include access to consultations, lab interpretation, prescriptions, and follow-up care delivered by Veyda's affiliated medical group. Those services are practiced by U.S.-licensed clinicians under separate Informed Consent and clinical-services agreements. The boundary between "Sage helping you understand your data" and "your Veyda physician advising on your care" is always clearly indicated in the product.

Not a medical device

The Veyda app and Sage AI assistant are not FDA-cleared medical devices. They do not diagnose, treat, cure, or prevent any disease. If you need diagnostic, monitoring, or therapeutic medical equipment, consult your physician.

Emergencies

If you are experiencing a medical emergency, call 911 or go to the nearest emergency room immediately.

Do not use Veyda to seek emergency medical attention. Veyda's response times — including from clinical staff — are not designed for emergencies.

If you are in crisis or having thoughts of suicide or self-harm, call or text the 988 Suicide and Crisis Lifeline at any time.

Supplements, peptides, and prescription medications

Products and protocols available through Veyda's marketplace and clinical services — including supplements, peptides, GLP-1 medications, and other prescriptions — are subject to additional clinical screening, regulatory restrictions, and our Marketplace Policies. Do not start, stop, or change any medication based solely on Veyda content without consulting your physician.

Your responsibility

You are responsible for the data you connect or upload, for sharing accurate information with our clinical team, and for following clinical guidance you receive. Withholding relevant medical history limits the safety and effectiveness of any care you receive through Veyda.

---

Counsel review queue — California considerations

Not final policy text. The items below capture the regulatory considerations our counsel needs to address before we publish the production version of this Medical Disclosure. Source: internal product/engineering review, May 2026.

Covered-entity scope (HIPAA + CMIA)

• Confirm whether Veyda, LLC is a HIPAA "covered entity" (provider/plan/clearinghouse) or only an "organized health care arrangement" + business associate of the affiliated medical group. Status determines which notices apply (Notice of Privacy Practices vs. CMIA-only).
• If Veyda directly orders lab work or operates the clinical service, covered-entity status is likely.
• CMIA (Cal. Civ. Code § 56) applies to health software regardless of HIPAA status — confirm separate notice + authorization requirements are met.
• Document the relationship between Veyda, LLC and the affiliated medical group (PC structure, MSO, fee splits — relevant for CA's corporate-practice-of-medicine rules).

Informed consent for AI-assisted health features

• Sage's AI reasoning across labs/wearables/symptoms may approach the "practice of medicine" line in some states. Confirm CA Medical Board guidance on AI-assisted clinical decision support.
• Specific consent should disclose:
  • Sage is informational, not diagnostic.
  • AI model can be wrong; member should verify with a clinician.
  • AI training: do we use member data to train models? Disclose.
  • Data sources Sage draws from (institutional research, citations).

Lab orders specifically

• Each lab order requires separate, written informed consent in CA — not blanketed by the membership signup. Build a per-order consent UI inside the app before any lab order ships.
• CLIA-certified lab partners require an "ordering provider" (physician). Document the chain: member orders → Veyda physician approves → lab fulfills.
• Disclose result-delivery model (in-app vs. through a clinician), turnaround expectations, what happens to leftover sample (destruction vs. storage), genetic-data handling if any panel includes genetic markers.
• For minors (if/when supported): parental consent + minor-consent carve-outs (Family Code §§ 6920–6929 — minors 12+ can consent to specific services like mental health, sexual/reproductive health, substance abuse without parental consent; general lab work is NOT a carve-out and requires parental consent).

Telehealth (when Veyda One launches)

• Telehealth-specific informed consent required (Health & Safety Code § 1374.16, § 2290.5).
• Provider licensure: clinicians must be licensed in the state where the patient is located at the time of consultation.
• Standard of care: same as in-person care under CA Bus & Prof Code § 2290.5(d).
• Recording: prohibited without separate explicit consent.

Prescriptions, GLP-1s, peptides, controlled substances

• Compounded peptides + DTC GLP-1s have evolving FDA/DEA scrutiny. Confirm compounding-pharmacy partner relationships are FDA-503A compliant.
• Telehealth-prescribed controlled substances: post–Ryan Haight Act + DEA telemedicine extensions, in-person evaluation may be required for certain schedules. Confirm scope of medications offered.

Emergency disclaimer + safety net

• The 911 / 988 disclaimer is required by FTC + state medical boards for any consumer health service. Keep it prominently styled (already in place).
• Consider adding: "This service is not for emergency mental health care. If you are in crisis, call 988 (Suicide & Crisis Lifeline) or text HOME to 741741 (Crisis Text Line)."

Specific items to revise in this draft

• Add: explicit AI training disclosure (does Sage train on member data?).
• Add: per-order lab consent flow reference.
• Add: telehealth section (when Veyda One launches).
• Confirm: HIPAA covered-entity status + corresponding NPP notice (separate doc?).